BerandaORCHPHARMA • NSE
add
Orchid Pharma Ltd
Tutup sebelumnya
₹713,85
Rentang hari
₹701,00 - ₹721,45
Rentang tahun
₹603,80 - ₹1.997,40
Kapitalisasi pasar
35,75Â M INR
Volume Rata-Rata
105,65Â rb
Rasio P/E
41,93
Hasil dividen
-
Bursa utama
NSE
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (INR) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 1,73Â M | -29,25% |
Biaya operasional | 685,42Â jt | -2,23% |
Laba bersih | 149,11Â jt | -49,20% |
Margin laba bersih | 8,62 | -28,23% |
Penghasilan per saham | — | — |
EBITDA | 141,58Â jt | -55,75% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (INR) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 1,80Â M | 4.871,20% |
Total aset | — | — |
Total liabilitas | — | — |
Total ekuitas | 12,67 M | — |
Saham yang beredar | 50,72 jt | — |
Harga terhadap nilai buku | 2,85 | — |
Tingkat pengembalian aset | — | — |
Tingkat pengembalian modal | 0,96% | — |
Arus Kas
Perubahan kas bersih
| (INR) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 149,11Â jt | -49,20% |
Kas dari operasi | — | — |
Kas dari investasi | — | — |
Kas dari pembiayaan | — | — |
Perubahan kas bersih | — | — |
Arus kas bebas | — | — |
Tentang
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai, founded on 1 July 1992. As of 2024, it was among the top fortune 500 Indian companies by market capitalization. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
Didirikan
1992
Situs
Karyawan
736
